Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.27 - $3.62 $478,970 - $763,820
-211,000 Reduced 28.15%
538,500 $1.22 Million
Q4 2021

Feb 14, 2022

BUY
$2.11 - $3.0 $1.26 Million - $1.79 Million
596,215 Added 388.96%
749,500 $2 Million
Q3 2021

Nov 15, 2021

BUY
$2.21 - $2.89 $338,759 - $442,993
153,285 New
153,285 $359,000
Q2 2020

Aug 14, 2020

SELL
$1.99 - $4.4 $2.31 Million - $5.11 Million
-1,162,108 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.81 - $5.03 $1.84 Million - $5.13 Million
1,019,108 Added 712.66%
1,162,108 $2.51 Million
Q4 2019

Feb 14, 2020

BUY
$2.84 - $4.25 $406,120 - $607,750
143,000 New
143,000 $489,000

About Aptinyx Inc.


  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.